Research Papers

25 of 261 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Highly expressed FAM189B predicts poor prognosis in hepatocellular carcinoma.
Ma W; Zhang X; Ma C; Liu P.
Pathol Oncol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Clinicopathological Features and Prognostic Evaluation of UBR5 in Liver Cancer Patients.
Huo Q; Hu J; Hou B; Zhao M; Han X; Du Y; Li Y.
Pathol Oncol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Improved Accuracy of Lymph Node Staging and Long-Term Survival Benefit in Colorectal Cancer With <i>Ex Vivo</i> Arteria…
Suszták N; Besznyák I; Almási K; Bursics A; Kelemen D; Borowski DW; Bánky B.
Pathol Oncol Res (Unknown)
Published: 2022
3/6 Transparent
Registered
Pulmonary Large Cell Neuroendocrine Carcinoma.
Yang L; Fan Y; Lu H.
Pathol Oncol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
EGFR T790M Mutation Detection in Patients With Non-Small Cell Lung Cancer After First Line EGFR TKI Therapy: Summary of…
Bencze E; Bogos K; Kohánka A; Báthory-Fülöp L; Sárosi V; Csernák E; Bittner N; Melegh Z; Tóth E.
Pathol Oncol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
On-Target Side Effects of Targeted Therapeutics of Cancer.
Tímár J; Uhlyarik A.
Pathol Oncol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellu…
Chen X; Hu G; Xiong L; Xu Q.
Pathol Oncol Res (Unknown)
Published: 2022
2/6 Transparent
Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cyto…
Takács F; Kotmayer L; Czeti Á; Szalóki G; László T; Mikala G; Márk Á; Masszi A; Farkas P; Plander M; Weisinger J; Demeter J; Fekete S; Szerafin L; Deák BM; Szaleczky E; Sulák A; Borbényi Z; Barna G.
Pathol Oncol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Establishment of a Novel Prognostic Prediction Model for Gastric Cancer Based on Necroptosis-Related Genes.
Zhu ZZ; Zhang G; Liu J.
Pathol Oncol Res (Unknown)
Published: 2022
2/6 Transparent
The Role of Stereotactic Radiotherapy in the Management of Melanoma, A Retrospective Single Institute Preliminary Study…
Kispál M; Jánváry LZ; Balatoni T; Gábor S; Fedorcsák I; Katalin B; Kenessey I; Liszkay G.
Pathol Oncol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The Pathologic Complete Response Ratio of Liver Metastases Represents a Valuable Prognostic Indicator.
Xu Y; He J; Li W; Zhang W; Liu S; He J; Pan Z; Lu Z; Peng J; Lin J.
Pathol Oncol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Clinicopathological Implications of ASAP1 Expression in Hepatocellular Carcinoma.
Bang S; Jee S; Son H; Cha H; Sim J; Kim Y; Park H; Myung J; Kim H; Paik S.
Pathol Oncol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
IL-33 Participates in the Development of Esophageal Adenocarcinoma.
Liu J; Liu L; Su Y; Wang Y; Zhu Y; Sun X; Guo Y; Shan J.
Pathol Oncol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Enhancing Natural Killer Cell-Mediated Cancer Immunotherapy by the Biological Macromolecule <i>Nocardia rubra</i> Cell-…
Wu J; He B; Miao M; Han X; Dai H; Dou H; Li Y; Zhang X; Wang G.
Pathol Oncol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Interaction Between Vascular Endothelial Growth Factor Gene Polymorphism and Smoking on Gastric Cancer Risk in Chinese …
Wang L; Xiao S; Zheng Y; Gao Z.
Pathol Oncol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Identification and Characterization of Genes Related to the Prognosis of Hepatocellular Carcinoma Based on Single-Cell …
Chen W; Zhang F; Xu H; Hou X; Tang D; Dai Y.
Pathol Oncol Res (Unknown)
Published: 2022
4/6 Transparent
Code Funding Declared
A Comprehensive Bioinformatic Analysis for Identification of Myeloid-Associated Differentiation Marker as a Potential N…
Zhou M; Chen Y; Gu X; Wang C.
Pathol Oncol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Mid-Infrared Imaging Characterization to Differentiate Lung Cancer Subtypes.
Kontsek E; Pesti A; Slezsák J; Gordon P; Tornóczki T; Smuk G; Gergely S; Kiss A.
Pathol Oncol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Identification and Validation of an m6A-Related LncRNA Signature to Predict Progression-Free Survival in Colorectal Can…
Zhang Y; Li L; Chu F; Xiao X; Zhang L; Li K; Wu H.
Pathol Oncol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The Prognostic Value of Eight Immunohistochemical Markers Expressed in the Tumor Microenvironment and on Hodgkin Reed-S…
Zijtregtop EAM; Tromp I; Dandis R; Zwaan CM; Lam KH; Meyer-Wentrup FAG; Beishuizen A.
Pathol Oncol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Association Between Vitamin D Binding Protein Gene Polymorphism (rs7041), Vitamin D Receptor, and 25-Hydroxyvitamin D S…
Amiri M; Elieh Ali Komi D; Vaisi-Raygani A; Kiani A; Moradi M; Aliyari M; Rahimi Z; Mohammadi-Noori E; Bashiri H.
Pathol Oncol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Cancer-Associated Stromal Fibroblast-Derived Transcriptomes Predict Poor Clinical Outcomes and Immunosuppression in Col…
Wang J; Akter R; Shahriar MF; Uddin MN.
Pathol Oncol Res (Unknown)
Published: 2022
3/6 Transparent
Data
Tumor-Derived Exosomal RNA From Fine-Needle Aspiration Supernatant as a Novel Liquid Biopsy for Molecular Diagnosis of …
Li G; Liu D; Flandrin P; Zhang Y; Lambert C; Mallouk N; Cottier M.
Pathol Oncol Res (Unknown)
Published: 2022
2/6 Transparent
Alterations of the Gut Microbiome in Patients With Pituitary Adenoma.
Hu J; Yang J; Chen L; Meng X; Zhang X; Li W; Li Z; Huang G.
Pathol Oncol Res (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Decreased Expression of Karyopherin-α 1 is Related to the Malignant Degree of Cervical Cancer and is Critical for the P…
Jiang L; Li D; Wang C; Liao J; Liu J; Wei Q; Wang Y.
Pathol Oncol Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared